Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony J Hardy

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Plos One|October 3, 2015
Prediction of Neurological Impairment in Cervical Spondylotic Myelopathy using a Combination of Diffusion MRI and Proton MR SpectroscopyBenjamin M Ellingson, Noriko Salamon, Anthony J Hardy, et al.
Medical Physics|March 21, 2019
Estimating fetal dose from tube current-modulated (TCM) and fixed tube current (FTC) abdominal/pelvis CT examinationsAnthony J Hardy, Erin Angel, Maryam Bostani, et al.
Medical Physics|October 31, 2020
Reference dataset for benchmarking fetal doses derived from Monte Carlo simulations of CT examsAnthony J Hardy, Maryam Bostani, Erin Angel, et al.
Medical Physics|August 18, 2018
Estimating lung, breast, and effective dose from low-dose lung cancer screening CT exams with tube current modulation across a range of patient sizesAnthony J Hardy, Maryam Bostani, Kyle McMillan, et al.
Medical Physics|December 20, 2018
Estimating a size-specific dose for helical head CT examinations using Monte Carlo simulation methodsAnthony J Hardy, Maryam Bostani, Andrew M Hernandez, et al.
Journal of Applied Clinical Medical Physics|May 3, 2021
A comparison of breast and lung doses from chest CT scans using organ-based tube current modulation (OBTCM) vs. Automatic tube current modulation (ATCM)Rick R Layman, Anthony J Hardy, Hyun J Kim, et al.
Journal of Neuro-Oncology|March 17, 2015
MRI perfusion measurements calculated using advanced deconvolution techniques predict survival in recurrent glioblastoma treated with bevacizumabRobert J Harris, Timothy F Cloughesy, Anthony J Hardy, et al.
Tomography (Ann Arbor, Mich.)|January 8, 2016
Diffusion MR Characteristics Following Concurrent Radiochemotherapy Predicts Progression-Free and Overall Survival in Newly Diagnosed GlioblastomaWarren Chang, Whitney B Pope, Robert J Harris, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Plos One|October 3, 2015
Prediction of Neurological Impairment in Cervical Spondylotic Myelopathy using a Combination of Diffusion MRI and Proton MR SpectroscopyBenjamin M Ellingson, Noriko Salamon, Anthony J Hardy, et al.
Medical Physics|March 21, 2019
Estimating fetal dose from tube current-modulated (TCM) and fixed tube current (FTC) abdominal/pelvis CT examinationsAnthony J Hardy, Erin Angel, Maryam Bostani, et al.
Medical Physics|October 31, 2020
Reference dataset for benchmarking fetal doses derived from Monte Carlo simulations of CT examsAnthony J Hardy, Maryam Bostani, Erin Angel, et al.
Medical Physics|August 18, 2018
Estimating lung, breast, and effective dose from low-dose lung cancer screening CT exams with tube current modulation across a range of patient sizesAnthony J Hardy, Maryam Bostani, Kyle McMillan, et al.
Medical Physics|December 20, 2018
Estimating a size-specific dose for helical head CT examinations using Monte Carlo simulation methodsAnthony J Hardy, Maryam Bostani, Andrew M Hernandez, et al.
Journal of Applied Clinical Medical Physics|May 3, 2021
A comparison of breast and lung doses from chest CT scans using organ-based tube current modulation (OBTCM) vs. Automatic tube current modulation (ATCM)Rick R Layman, Anthony J Hardy, Hyun J Kim, et al.
Journal of Neuro-Oncology|March 17, 2015
MRI perfusion measurements calculated using advanced deconvolution techniques predict survival in recurrent glioblastoma treated with bevacizumabRobert J Harris, Timothy F Cloughesy, Anthony J Hardy, et al.
Tomography (Ann Arbor, Mich.)|January 8, 2016
Diffusion MR Characteristics Following Concurrent Radiochemotherapy Predicts Progression-Free and Overall Survival in Newly Diagnosed GlioblastomaWarren Chang, Whitney B Pope, Robert J Harris, et al.
Pageof 1